Antidepressants While Breastfeeding: What’s Safe

Which antidepressants are safe while breastfeeding?

Antidepressants while breastfeeding are usually safe to continue, and sertraline and paroxetine have the strongest safety record. The CDC states that mothers with postpartum depression can usually continue to breastfeed. Stopping a medication that works is not automatically safer, because untreated depression carries its own documented risks.

After birth, treatment usually starts with an SSRI, or selective serotonin reuptake inhibitor, the type with the most breastfeeding data behind it. Zoloft is the brand name for sertraline; both names mean the same medication.

The question we hear most often at a first postpartum visit is whether you have to choose between treatment and nursing. For almost every woman who asks us, the answer is no. What follows is the Zoloft answer and the numbers behind it.

Is Zoloft safe while breastfeeding?

Zoloft (sertraline) is considered safe for most breastfeeding women and is the antidepressant prescribers usually reach for first after birth. It passes into breast milk in very small amounts, and infant blood levels are typically undetectable. LactMed, the NIH lactation database, lists it as a preferred antidepressant during breastfeeding.

Most of what we know about Zoloft and breastfeeding comes from women who kept nursing on it while their milk and babies’ blood were tested. The FDA label reports low levels in human milk, with breastfed infants averaging 2% of the sertraline blood levels measured in their mothers.

If you are already taking it and doing well, the usual plan is to stay on it: the Academy of Breastfeeding Medicine’s protocol advises continuing the same medication if it controlled your symptoms well during pregnancy. It adds a point worth holding onto: exposure through milk is far lower than in pregnancy.

If you are starting fresh after birth, the protocol names sertraline an appropriate first choice: lower levels in milk and infant blood than most alternatives.

Either way, do not stop on your own.

How much sertraline actually reaches your baby

Sertraline (Zoloft) reaches a breastfed baby at about 1% or less of the mother’s weight-adjusted dose, far under the roughly 10% level usually considered safe while breastfeeding. That figure is the relative infant dose, and it is how prescribers judge any medication in milk. Most sertraline breastfeeding studies land between 0.5% and 1%.

It compares what the baby takes in through milk each day, per kilogram of body weight, with what the mother takes per kilogram of hers. Anything under about 10% has counted as compatible since the World Health Organization backed that cutoff in the late 1980s. Sertraline sits near 0.5%, a twentieth of that limit.

The blood work agrees. In one group of 30 breastfed infants, 22 had no detectable sertraline at all.

A medication showing up in milk is not the same as a medication harming a baby. Almost everything you consume shows up in milk in traces. What matters is the dose and what follow-up shows.

Where the other antidepressants stand

Zoloft and Lexapro are both used while breastfeeding, and sertraline edges ahead as first-line because more studies back it and less passes into milk. A woman already stable on escitalopram is usually kept on it, since changing a working medication carries its own risk.

Prescribers sort them into three groups.

A review in the Academy of Breastfeeding Medicine’s protocol found infant blood levels of paroxetine and sertraline undetectable in most cases, while citalopram and fluoxetine showed levels above 10% of the mother’s in 17% and 22% of cases. That is a different 10% from the dose measure above. Fluoxetine’s complication is norfluoxetine, a leftover byproduct that lingers and was detectable in every infant in one study. Among the tricyclics, nortriptyline is the one with enough reported cases to judge, and it is generally undetectable in infant blood. The advice about staying on what already works applies across these classes too.

The table cannot show whether a medication actually works for you, which counts for a lot.

What untreated postpartum depression costs

The other half rarely gets equal weight. Depression after birth is common, affecting about 1 in 8 women with a recent live birth, and leaving it untreated is not neutral.

The Academy of Breastfeeding Medicine is blunt. Untreated maternal depression can have serious, long-term effects on mother and infant: it can disrupt the family, interfere with bonding, lead to stopping breastfeeding early, and affect infant growth and brain development. Infants of depressed mothers engage less and are at higher risk of poor weight gain.

So the choice is almost never medication risk against no risk. What you are weighing is a small exposure we can watch against a well-documented harm, and none of that makes weaning a failure. Women stop nursing for many reasons.

Medication is also not the only treatment for depression after birth: our postpartum depression page covers the full range of options, and our guide to baby blues or postpartum depression walks through the difference. If you are having thoughts of harming yourself or your baby, get help today: call or text 988, or go to your nearest emergency department.

Starting or continuing an antidepressant, and what to watch in your baby

Babies exposed to Zoloft (sertraline) through breast milk are watched for unusual sleepiness or irritability, feeding changes, and slower weight gain. Those effects are uncommon at the amounts that reach a baby, and reported cases cleared within days. Routine blood tests on the baby are not standard care.

If a medication is controlling your symptoms, staying on it is the default, across SSRIs, SNRIs, and tricyclics alike; starting one after birth usually means beginning with one of the preferred options above. Switching a stable medication to breastfeed is usually the worse trade: you take on the risk of a change to solve a problem you may not have.

Stopping abruptly is the one thing to avoid. The FDA label advises a gradual reduction rather than stopping all at once, and lists nausea, dizziness, insomnia, and mood changes among the effects. Relapse is the larger worry, and the postpartum months are a bad time to risk it.

The evidence on exposed babies is reassuring. In one group of 26 breastfed infants, none had a detectable reaction. In another study, 5 of 38 showed something (restlessness, poor feeding, disrupted sleep) that cleared within three days of stopping the medication. No developmental effects have turned up in infants followed to five years of age.

A preterm or medically fragile baby processes medication more slowly, and rare cases of buildup have been reported.

The next step is an evaluation. Our clinicians handle perinatal medication management at a Pennsylvania psychiatry practice with in-person care and secure video visits statewide.

Common questions about antidepressants and breastfeeding

General information, not medical advice. This page carries no dosing guidance and cannot account for your history, your baby’s health, or your other medications. Talk with your own prescriber before starting, changing, or stopping any medication. If you are in crisis, call or text 988.